Company: CRVO
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001437749-25-013543
Chunk: 58

Company: CervoMed Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 58
---
 Merger vest in equal monthly installments over 36 months from the grant date. As of December 31, 2024, there were no shares available for issuance under the 2018 Equity Plan.

<div align='center'>31

PROPOSAL NO. 4

APPROVAL OF CERVOMED INC. 2025 EQUITY INCENTIVE PLAN</div>

Introduction

On April 14, 2025, the Board, upon recommendation of the Compensation Committee, unanimously approved the CervoMed Inc. 2025 Equity Incentive Plan (referred to in this section as the “2025 Plan”), subject to approval by our stockholders at the Annual Meeting.

The 2025 Plan provides for the grant of incentive and non-statutory stock options, stock appreciation rights, restricted stock, RSUs, performance awards, stock bonuses and other stock-based awards. The Board and Compensation Committee believe the 2025 Plan provides a means to attract and retain qualified individuals to perform services for our Company, by providing incentive compensation for such individuals that is linked to the growth and profitability of our Company and increases in stockholder value, and aligning the interests of such individuals with the interests of our stockholders through opportunities for equity participation in our Company. Historically, we have granted equity-based awards outside any stockholder approved plan, or through our 2015 Equity Plan and 2018 Equity Plan.

In the following discussion, we refer to both incentive stock options and non-statutory stock options as “options,” and to options, stock appreciation rights, restricted stock awards, RSUs, performance awards and stock bonuses as “incentive awards.”

Reasons Why You Should Vote in Favor of the Approval of the 2025 Plan

The Board recommends a vote for the approval of the 2025 Plan because the Board believes the 2025 Plan is in the best interests of our Company and stockholders for the following reasons:

| ● | Aligns Director, Executive Officer, Employee and Stockholder Interests.  We currently provide long-term incentives in the form of stock option grants to our directors and employees, including our executive officers.  We believe that our equity-based compensation programs help align the interests of our directors, executive officers and other employees with the interests of our stockholders.  We believe that our long-term equity-based incentives help promote long-term retention of our employees and encourage significant ownership of our common stock.  If the 2025 Plan is approved, we will be able to align the interests